share_log

TCR2 Therapeutics | 4: Statement of changes in beneficial ownership of securities-10% Owner MPM BioVentures 2014, L.P.

SEC ·  Jun 6, 2023 04:36
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.